Drinking coffee or tea may be beneficial for physical function in ageing   

08 Feb 2022

Medical education goes Holographic with mixed reality from Microsoft

NUS Yong Loo Lin School of Medicine partners with Microsoft to useholographic technology to teach medical and nursing undergraduates

08 Feb 2022

Antibody from recovered COVID-19 patients found to reduce severity of disease

Study found that an antibody, P36-5D2, demonstrated a substantial decrease in infectious virus load in the lungs and brain, and reduced lung disease in laboratory models

13 Jan 2022

Antibody from recovered COVID-19 patients found to reduce severity of disease

Researchers at NUS Medicine and Beijing Tsinghua University found that an antibody, P36-5D2, demonstrated a substantial decrease in infectious virus load in the lungs and brain, and reduced lung disease in laboratory models.

11 Jan 2022

Medical education goes Holographic with mixed reality from Microsoft

NUS Yong Loo Lin School of Medicine partners with Microsoft to use holographic technology to teach medical and nursing undergraduates.

13 Dec 2021

NUS Yong Loo Lin School of Medicine students and researchers develop novel algorithm to assess immunotherapy benefit in stomach cancer patients

Led by Assistant Professor Raghav Sundar from the Department of Medicine at NUS Medicine, the team of three fifth-year medical students and one third-year medical student ran the algorithm through over 500,000 simulations to demonstrate its robustness and explore its limits of error.

11 Dec 2021

NUS Medicine and Duke-NUS researchers to study immune response of COVID-19 vaccines in children

Led by Asst Prof Elizabeth Tham, researchers from NUS Yong Loo Lin School of Medicine and Duke-NUS Medical School are working together to recruit participants for a non-interventional observational study aimed at studying immune responses to COVID-19 vaccines in different groups of children Contact the study team at marvels@nuhs.edu.sg.

08 Dec 2021

NUS Medicine cardiovascular research team develops anticoagulant drugs with high anti-clotting efficacy and minimal bleeding

 A team led by Research Assistant Prof Koh Cho Yeow and Associate Prof Mark Chan from the Yong Loo Lin School of Medicine, as well as Prof R. Manjunatha Kini from the NUS Department of Biological Sciences searched tick saliva for novel anticlotting proteins and then modified the amino acid sequences of these proteins to produce these powerful anticoagulants with high anticlotting efficacy but minimal bleeding.

30 Nov 2021

NUS researchers discover novel mechanisms of memory formation in little-known hippocampal CA2 sub-region

 NUS Medicine PhD student, Amrita Benoy and Associate Professor Sajikumar Sreedharan, from the Healthy Longevity Translational Research Programme, discovered that the CA2 sub-region of the hippocampus is critical in social memory formation, which guides social interactions.

12 Nov 2021

Clinician-scientists develop new glaucoma implant that reduces eye pressure, preserves vision

Led by Prof Paul Chew, a NUHS team developed a new glaucoma implant that reduces patients’ eye pressure for a longer period of time, enables less reliance on eye drops and prevents further progression of the disease that leads to blindness.

03 Nov 2021

NUS researchers discover possible new treatment option for aggressive forms of breast cancer

NUS Medicine researchers discover possible new treatment option for aggressive and difficult-to-treat forms of breast cancer in drugs used to treat diabetes.